Evaluation of WellAir’s Protect 800/900 and Defend 1050 in Hospital ICUs

I. Arıkan, O. Genc, C. Uyar, M.E. Tokur, C. Balcı, D. Percin Renders


Hospital ICUs, Turkey


To detect the number and types of micro-organisms present in the air and on high-touch surfaces in ICUs, and to evaluate the effectiveness of air purifiers in reducing the microbial load and thus the rate of nosocomial infections in ICUs.


This intervention study was conducted in two similar ICUs between May to November 2020. WellAir’s (Novaerus) air purifiers were located in the intervention ICU for two months. Routine cleaning procedures and high-efficiency particulate air filtration continued in the control ICU as well as in the intervention ICU. After two months, the air purifiers were moved to the other ICU for the next two months to reduce any possible bias in the results. Air and surface samples were evaluated.

Summary of Results

The evaluation of the change in the intervention ICU over time revealed a significantly lower colony concentration in the air and on surfaces on day 60 compared to day 1 (P_air<0.001 and P_surface<0.001). There was a significant positive correlation between the number of colonies detected and the rate of hospital-acquired infections in the intervention ICU (r=0.406, P=0.049) and in the control ICU (r=0.698, P=0.001).

Above Figure: Distribution of the rate of hospital-acquired infections by study period in intensive care units in both phases of the study. August was the period without air purifiers. Phase 1, May 15 – July 15; Phase 2, September 15 – November 15.


Using WellAir’s NOVAERUS (Protect 800/900 and Defend 1050) air purifiers, in addition to the hospital HVAC systems, may be an effective way to reduce the microbial load in the air and surfaces and thus hospital-acquired infections.

Download the Full Report